Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
10/2004
10/20/2004EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004EP1467695A2 Hiv integrase inhibitors
10/20/2004EP1002791B1 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
10/20/2004CN1538842A Atineoplastic combinations
10/20/2004CN1171859C Fungicide and insecticide benzyloxycyclopropyl substituted aromatic compound fungicide
10/20/2004CN1171855C Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindopril
10/19/2004US6806384 Production method of β-amino-α-hydroxycarboxylic acid
10/14/2004WO2004087932A2 Enzymatic resolution of (±) methyl trans-3-phenyl glycidate
10/14/2004WO2004087650A2 Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
10/14/2004WO2004087064A2 Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase
10/14/2004WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages)
10/14/2004WO2003061595A3 Antibodies against and compositions containing new amphetamine derivatives
10/14/2004US20040204610 Catalysts
10/14/2004US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/14/2004CA2522147A1 Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase
10/13/2004EP1466907A1 Process for producing quinazolin-4-one and derivative thereof
10/13/2004EP1466890A1 Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes
10/13/2004EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004EP1466585A2 Use of of aminosubstituted hydroxybenzophenones as photostable UV-filter in cosmetic and pharmaceutical preparations
10/13/2004EP1213284B1 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives
10/13/2004EP0999204B1 Novel compound having effect of promoting neuron differentiation
10/13/2004CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
10/13/2004CN1536994A Hypoglycemic agent
10/13/2004CN1170812C Method for synthesizing diphenyl-keto-acid derivative
10/13/2004CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy
10/12/2004US6803487 Reacting isobutylene, ethylene and mineral acid;hydrolysis of corresponding ester to alcohol; catalytic dehydrogenation
10/12/2004CA2100817C Heteroacetic acid derivatives
10/07/2004WO2004085661A2 Process to chiral beta-amino acid derivatives
10/07/2004WO2004065361A3 Cyclopropyl beta-amino acid derivatives
10/07/2004US20040199007 Raney copper
10/07/2004US20040198977 novel sunscreen agents such as Dipotassium Salt of 2-(4-acetamidobenzylidene)malonic Acid or Dipiperidinium Salt of 2-(4-aminobenzylidene)malonic Acid; absorbing within the region of UV-B radiation; cosmetics; photostability, water solubility
10/07/2004US20040198974 applying deemed racemates to continuos enantioselective liquid chromatography like SMB (simulated moving bed); for industrial scale production of pure enantiomers of amino acids useful as intermediates in organic synthesis such as N-benzyloxycarbonyl-tert-leucine
10/07/2004US20040198777 obesity; antidiabetic agents; Alzheimer's disease; Huntington's disease;schizophrenia; antiproliferative agents; anticancer agents; antiepileptic agents; deafness
10/06/2004EP1464638A1 Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
10/06/2004EP1463713A1 Prodrugs of excitatory amino acids
10/06/2004EP1463712A1 New anhydrous crystalline forms of gabapentin
10/06/2004EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004EP1463699A2 Process for the production of 3-phenylisoserine
10/06/2004EP0975560A4 Chiral separations of amino acids
10/06/2004CN1535260A Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids
10/06/2004CN1535151A Novel anti-infectives
10/06/2004CN1534016A Calcium acceptor active compound
10/06/2004CN1534013A Preparation method of water soluble curcumin composition salt
10/06/2004CN1169781C Prcess for prepn. of salts of L-carnitine and alkanoyl L-carnitine with mucic acid
10/06/2004CN1169580C 166 Ho-DTPA, its preparing method and application as liquid radiation source
10/05/2004US6800782 Dehydrating gabapentin monohydrate to form crystalline gabapentin dehydrate form a, allowing dehydrate a to stand at ambient temperatures to form crystalline gabapentin dehydrate form b
10/05/2004US6800764 Process for the synthesis of chirally pure beta-amino-alcohols
10/05/2004US6800185 Method for producing basic amino acid solution
10/05/2004US6800097 For dyeing keratin fibers; hair dyes
10/05/2004CA2156024C Synthetic excitatory amino acids
09/2004
09/30/2004WO2004083163A1 3-AMINO-3-ARYLPROPIONIC ACID n-ALKYL ESTERS, PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 3-AMINO-3-ARYLPROPIONIC ACIDS AND ESTERS OF THE ANTIPODES THERETO
09/30/2004WO2004082592A2 Metal amino acid chelates having nutritionally relevant anion radical (s)
09/30/2004WO2004058683A3 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
09/30/2004US20040192954 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2-[18f]-fluoroethyl)-l-tyrosine
09/30/2004US20040192779 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
09/30/2004US20040192775 Stable carnitine or carnitine acetyl ester; dietetics, nutraceutine, drugs
09/30/2004US20040192741 Calcilytic compounds
09/30/2004US20040192623 Aloe-emodin derivatives and their use in the treatment of neoplasias
09/30/2004US20040192617 Making gabapentin tannate to treat central nervous system disorders by reacting gabapentin and tannic acid; improves certain organoleptic properties such as taste
09/30/2004US20040187770 Rotor-stator apparatus and process for the formation of particles
09/29/2004EP1461332A2 Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids
09/29/2004EP1461307A2 Crystallization of amino acids using ultrasonic agitation
09/29/2004EP1461303A2 PROCESS FOR THE SYNTHESIS OF CHIRALLY PURE b-AMINO-ALCOHOLS
09/29/2004EP1461014A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
09/29/2004EP1460994A2 Compounds for a controlled release of active molecules
09/29/2004EP1210320B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
09/29/2004EP1192166B1 Group(vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
09/29/2004EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
09/29/2004EP1144367B1 Alpha-substitution of unprotected beta-amino ester compounds
09/29/2004EP1004571B1 Processes for producing amino acid having secondary or tertiary amino group and three or more carboxyl groups and its salt
09/29/2004CN1533400A Probes, system and methods for drug discovery
09/29/2004CN1533381A Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
09/29/2004CN1532181A Intermediate for preparing benzo-oxazine derivative and its preparing method
09/29/2004CN1532180A Extracting method for natural amino acid mixture with rich 4-hydroxy-isolecine
09/29/2004CN1168703C Secondary aspartic acid amide esters
09/29/2004CN1168701C Method for purifying branched chain amino acids
09/28/2004US6797827 Process for the preparation of alpha-amino acids by hydrolysis of hydantoins at elevated pressure and elevated temperature
09/28/2004US6797731 Resorcinol derivatives
09/28/2004US6797281 Esters of I-carnitine or alkanoyl I-carnitines
09/23/2004WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use
09/23/2004US20040186313 via diethyl-3-methoxyacetoxyglutaric acid as intermediate; deblocking, deprotecting; Friedel-Crafts acylation; hydroxymethylglutaryl coenzyme a reductase inhibitors; anticholesterol agents
09/23/2004US20040186312 Solid-phase electrophilic fluorination
09/23/2004US20040186177 treating a disorder selected from obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, post traumatic stress syndrome (PTSD), restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia
09/23/2004US20040186175 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
09/22/2004EP1460058A1 Diaminodicarboxylic acids and intermediates thereof
09/22/2004EP1459765A1 6-fluorobicyclo 3.1.0 hexane derivatives
09/22/2004EP1458671A1 Prodrugs of excitatory amino acids
09/22/2004EP1458670A1 Method for producing 2-halogenacyl-3-amino-acrylic acid derivatives
09/22/2004EP1458481A1 Catalysts for producing carboxylic acid salts
09/22/2004EP1200389B1 Process for preparing betaines
09/22/2004CN1167669C New method of preparing levo-carnitine tartrate
09/22/2004CN1167668C N,N-disubstituted glycine ester synthesis method
09/21/2004US6794542 Method for the preparation of enantiomerically enriched compounds
09/21/2004US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide
09/21/2004US6794492 N-(2,2,2-trifluoroethyl)glycine derivatives; can be used to prepare lipophilic proteins adapted for crossing the blood brain barrier
09/21/2004US6794413 Compounds and related methods for inhibition of γ-aminobutyric acid aminotransferase
09/21/2004US6794331 Raney copper which is doped with at least one metal from the group comprising iron and/or noble metals is used as a catalyst in the dehydrogenation of alcohols.
09/21/2004US6793825 An extraction agent which contains at least partially relatively long-chain organic compounds and at least one liquid cation exchanger, and a membrane that is wettable by either aqueous mixture or by extraction agent; extraction
09/21/2004CA2121020C Process to prepare amino carboxylic acid salts
09/16/2004US20040181065 Process for preparing 2-amino-4-(4-fluorphenyl) -6-alkylpyrimidine-5-carboxylate